Categories
Cancer Clinical trials Complementary and alternative medicine Quackery

Crank spin versus science on mammography

Sometimes when a study comes out that I’m very interested in blogging about, I don’t get around to it right away. In the blogging biz, this sort of delay is often considered a bad thing, because blogging tends to be very immediate, about being the firstest with the mostest, and the moment to strike and […]

Categories
Cancer Politics

"Overselling" mammography?

One issue that keeps coming up time and time again for me is the issue of screening for cancer. Because I’m primarily a breast cancer surgeon in my clinical life, that means mammography, although many of the same issues come up time and time again in discussions of using prostate-specific antigen (PSA) screening for prostate […]

Categories
Cancer Clinical trials Medicine

Better late than never: The Swedish mammography study and screening for women under 50

Last week blew by me in a blur. Because I was in full grant writing frenzy to get an R01 in the can by Friday, pretty much anything that wasn’t totally urgent got shoved aside, at least after Wednesday. Of course, it was last Wednesday that yet another mammography study was being touted as a […]

Categories
Cancer Clinical trials Medicine

The mammography wars heat up again

Unfortunately, it’s grant application crunch time again over the weekend. That means something’s got to give, and what happened to be the thing to give was this blog. Fortunately, all is not lost, as a “good friend” of mine has commented on a recent New England Journal of Medicine study from Thursday about mammography. It […]

Categories
Cancer Clinical trials Medicine Politics

The USPSTF mammography guidelines and African American women: Do they even apply?

A while back I wrote about really rethinking how we screen for breast cancer using mammography. Basically, the USPSTF, an independent panel of physicians and health experts that makes nonbinding recommendations for the government on various health issues, reevaluated the evidence for routine screening mammography and concluded that for women at normal risk for breast […]